Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00451724 · ClinicalTrials.gov registry record · Phase 2
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
A Phase 2 study of Laceration, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT00451724 is a Phase 2 study of Laceration that has completed, run by Rhode Island Hospital. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00451724, a Phase 2 study of Laceration, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
Conditions Studied
Interventions
- DRUG Intranasal ketamine
Study Locations (1)
Rhode Island
- Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00451724
The ClinicalTrials.gov registry entry for NCT00451724 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Laceration appearing as the primary indexed condition, and to 1 intervention - of which Intranasal ketamine is the first listed.
NCT00451724 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00451724 about?
NCT00451724 is a clinical study titled "Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair". The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
What is the current status of trial NCT00451724?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2007-05. Estimated completion is 2010-02.
What conditions does trial NCT00451724 study?
This clinical trial studies the following conditions: Laceration.
What interventions are being tested in trial NCT00451724?
The interventions under investigation include: Intranasal ketamine (DRUG).
Who is sponsoring clinical trial NCT00451724?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00451724 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.